APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

NADPH Oxidase 4

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global NADPH Oxidase 4 Market Analysis and Forecast 2026-2032

Report ID 174015490222 December 2025193 pages

Choose your research edition.

Industry ResearchNADPH Oxidase 4 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal NADPH Oxidase 4 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal NADPH Oxidase 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NADPH Oxidase 4 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NADPH Oxidase 4 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global NADPH Oxidase 4 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for NADPH Oxidase 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for NADPH Oxidase 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for NADPH Oxidase 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for NADPH Oxidase 4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of NADPH Oxidase 4 include Bioasis Technologies Inc, GenKyoTex SA and Glucox Biotech AB, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for NADPH Oxidase 4, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of NADPH Oxidase 4, also provides the sales of main regions and countries. Of the upcoming market potential for NADPH Oxidase 4, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NADPH Oxidase 4 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global NADPH Oxidase 4 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for NADPH Oxidase 4 sales, projected growth trends, production technology, application and end-user industry.

NADPH Oxidase 4 Segment by Company

Bioasis Technologies Inc

GenKyoTex SA

Glucox Biotech AB

NADPH Oxidase 4 Segment by Type

MTfp-siRNA

GKT-831

GKT-136901

Others

NADPH Oxidase 4 Segment by Application

Liver Fibrosis

Ischemic Stroke

Kidney Fibrosis

Kidney Disease

Others

NADPH Oxidase 4 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NADPH Oxidase 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NADPH Oxidase 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NADPH Oxidase 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of NADPH Oxidase 4 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of NADPH Oxidase 4 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NADPH Oxidase 4 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NADPH Oxidase 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MTfp-siRNA Major Manufacturers Table 3. GKT-831 Major Manufacturers Table 4. GKT-136901 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global NADPH Oxidase 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Liver Fibrosis Major Manufacturers Table 8. Ischemic Stroke Major Manufacturers Table 9. Kidney Fibrosis Major Manufacturers Table 10. Kidney Disease Major Manufacturers Table 11. Others Major Manufacturers Table 12. NADPH Oxidase 4 Industry Trends Table 13. NADPH Oxidase 4 Industry Drivers Table 14. NADPH Oxidase 4 Industry Opportunities and Challenges Table 15. NADPH Oxidase 4 Industry Restraints Table 16. Global NADPH Oxidase 4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global NADPH Oxidase 4 Revenue by Region (2021-2026) & (US$ Million) Table 18. Global NADPH Oxidase 4 Revenue by Region (2027-2032) & (US$ Million) Table 19. Global NADPH Oxidase 4 Revenue Market Share by Region (2021-2026) Table 20. Global NADPH Oxidase 4 Revenue Market Share by Region (2027-2032) Table 21. Global NADPH Oxidase 4 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global NADPH Oxidase 4 Sales by Region (2021-2026) & (k units) Table 23. Global NADPH Oxidase 4 Sales by Region (2027-2032) & (k units) Table 24. Global NADPH Oxidase 4 Sales Market Share by Region (2021-2026) Table 25. Global NADPH Oxidase 4 Sales Market Share by Region (2027-2032) Table 26. Global NADPH Oxidase 4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global NADPH Oxidase 4 Revenue Market Share by Manufacturers (2021-2026) Table 28. Global NADPH Oxidase 4 Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global NADPH Oxidase 4 Sales Market Share by Manufacturers (2021-2026) Table 30. Global NADPH Oxidase 4 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global NADPH Oxidase 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global NADPH Oxidase 4 Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global NADPH Oxidase 4 Manufacturers, Product Type & Application Table 34. Global NADPH Oxidase 4 Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global NADPH Oxidase 4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global NADPH Oxidase 4 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 39. Global NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 40. Global NADPH Oxidase 4 Revenue Market Share by Type (2021-2026) Table 41. Global NADPH Oxidase 4 Revenue Market Share by Type (2027-2032) Table 42. Global NADPH Oxidase 4 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 44. Global NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 45. Global NADPH Oxidase 4 Sales Market Share by Type (2021-2026) Table 46. Global NADPH Oxidase 4 Sales Market Share by Type (2027-2032) Table 47. Global NADPH Oxidase 4 Price by Type (2021-2026) & (US$/unit) Table 48. Global NADPH Oxidase 4 Price by Type (2027-2032) & (US$/unit) Table 49. Global NADPH Oxidase 4 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 51. Global NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 52. Global NADPH Oxidase 4 Revenue Market Share by Application (2021-2026) Table 53. Global NADPH Oxidase 4 Revenue Market Share by Application (2027-2032) Table 54. Global NADPH Oxidase 4 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 56. Global NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 57. Global NADPH Oxidase 4 Sales Market Share by Application (2021-2026) Table 58. Global NADPH Oxidase 4 Sales Market Share by Application (2027-2032) Table 59. Global NADPH Oxidase 4 Price by Application (2021-2026) & (US$/unit) Table 60. Global NADPH Oxidase 4 Price by Application (2027-2032) & (US$/unit) Table 61. Bioasis Technologies Inc Company Information Table 62. Bioasis Technologies Inc Business Overview Table 63. Bioasis Technologies Inc NADPH Oxidase 4 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Bioasis Technologies Inc NADPH Oxidase 4 Product Portfolio Table 65. Bioasis Technologies Inc Recent Development Table 66. GenKyoTex SA Company Information Table 67. GenKyoTex SA Business Overview Table 68. GenKyoTex SA NADPH Oxidase 4 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. GenKyoTex SA NADPH Oxidase 4 Product Portfolio Table 70. GenKyoTex SA Recent Development Table 71. Glucox Biotech AB Company Information Table 72. Glucox Biotech AB Business Overview Table 73. Glucox Biotech AB NADPH Oxidase 4 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Glucox Biotech AB NADPH Oxidase 4 Product Portfolio Table 75. Glucox Biotech AB Recent Development Table 76. North America NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 77. North America NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 78. North America NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 79. North America NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 80. North America NADPH Oxidase 4 Sales Price by Type (2021-2026) & (US$/unit) Table 81. North America NADPH Oxidase 4 Sales Price by Type (2027-2032) & (US$/unit) Table 82. North America NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 83. North America NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 84. North America NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 85. North America NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 86. North America NADPH Oxidase 4 Sales Price by Application (2021-2026) & (US$/unit) Table 87. North America NADPH Oxidase 4 Sales Price by Application (2027-2032) & (US$/unit) Table 88. North America NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America NADPH Oxidase 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America NADPH Oxidase 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 92. North America NADPH Oxidase 4 Sales by Country (2021-2026) & (k units) Table 93. North America NADPH Oxidase 4 Sales by Country (2027-2032) & (k units) Table 94. North America NADPH Oxidase 4 Sales Price by Country (2021-2026) & (US$/unit) Table 95. North America NADPH Oxidase 4 Sales Price by Country (2027-2032) & (US$/unit) Table 96. United States NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 97. Canada NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 98. Mexico NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 99. Europe NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 102. Europe NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 103. Europe NADPH Oxidase 4 Sales Price by Type (2021-2026) & (US$/unit) Table 104. Europe NADPH Oxidase 4 Sales Price by Type (2027-2032) & (US$/unit) Table 105. Europe NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 108. Europe NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 109. Europe NADPH Oxidase 4 Sales Price by Application (2021-2026) & (US$/unit) Table 110. Europe NADPH Oxidase 4 Sales Price by Application (2027-2032) & (US$/unit) Table 111. Europe NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe NADPH Oxidase 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe NADPH Oxidase 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 115. Europe NADPH Oxidase 4 Sales by Country (2021-2026) & (k units) Table 116. Europe NADPH Oxidase 4 Sales by Country (2027-2032) & (k units) Table 117. Europe NADPH Oxidase 4 Sales Price by Country (2021-2026) & (US$/unit) Table 118. Europe NADPH Oxidase 4 Sales Price by Country (2027-2032) & (US$/unit) Table 119. Germany NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 120. France NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 121. U.K. NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 122. Italy NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 123. Russia NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 124. Spain NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 125. Netherlands NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 126. Switzerland NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 127. Sweden NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 128. Poland NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 129. China NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 130. China NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 131. China NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 132. China NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 133. China NADPH Oxidase 4 Sales Price by Type (2021-2026) & (US$/unit) Table 134. China NADPH Oxidase 4 Sales Price by Type (2027-2032) & (US$/unit) Table 135. China NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 136. China NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 137. China NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 138. China NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 139. China NADPH Oxidase 4 Sales Price by Application (2021-2026) & (US$/unit) Table 140. China NADPH Oxidase 4 Sales Price by Application (2027-2032) & (US$/unit) Table 141. Asia NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 144. Asia NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 145. Asia NADPH Oxidase 4 Sales Price by Type (2021-2026) & (US$/unit) Table 146. Asia NADPH Oxidase 4 Sales Price by Type (2027-2032) & (US$/unit) Table 147. Asia NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 150. Asia NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 151. Asia NADPH Oxidase 4 Sales Price by Application (2021-2026) & (US$/unit) Table 152. Asia NADPH Oxidase 4 Sales Price by Application (2027-2032) & (US$/unit) Table 153. Asia NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia NADPH Oxidase 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia NADPH Oxidase 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 157. Asia NADPH Oxidase 4 Sales by Country (2021-2026) & (k units) Table 158. Asia NADPH Oxidase 4 Sales by Country (2027-2032) & (k units) Table 159. Asia NADPH Oxidase 4 Sales Price by Country (2021-2026) & (US$/unit) Table 160. Asia NADPH Oxidase 4 Sales Price by Country (2027-2032) & (US$/unit) Table 161. Japan NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 162. South Korea NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 163. India NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 164. Australia NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 165. Taiwan NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 167. SAMEA NADPH Oxidase 4 Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA NADPH Oxidase 4 Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA NADPH Oxidase 4 Sales by Type (2021-2026) & (k units) Table 170. SAMEA NADPH Oxidase 4 Sales by Type (2027-2032) & (k units) Table 171. SAMEA NADPH Oxidase 4 Sales Price by Type (2021-2026) & (US$/unit) Table 172. SAMEA NADPH Oxidase 4 Sales Price by Type (2027-2032) & (US$/unit) Table 173. SAMEA NADPH Oxidase 4 Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA NADPH Oxidase 4 Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA NADPH Oxidase 4 Sales by Application (2021-2026) & (k units) Table 176. SAMEA NADPH Oxidase 4 Sales by Application (2027-2032) & (k units) Table 177. SAMEA NADPH Oxidase 4 Sales Price by Application (2021-2026) & (US$/unit) Table 178. SAMEA NADPH Oxidase 4 Sales Price by Application (2027-2032) & (US$/unit) Table 179. SAMEA NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA NADPH Oxidase 4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA NADPH Oxidase 4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. SAMEA NADPH Oxidase 4 Sales by Country (2021-2026) & (k units) Table 184. SAMEA NADPH Oxidase 4 Sales by Country (2027-2032) & (k units) Table 185. SAMEA NADPH Oxidase 4 Sales Price by Country (2021-2026) & (US$/unit) Table 186. SAMEA NADPH Oxidase 4 Sales Price by Country (2027-2032) & (US$/unit) Table 187. Brazil NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 188. Argentina NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 189. Chile NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 190. Colombia NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 191. Peru NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 193. Israel NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 194. UAE NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 195. Turkey NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 196. Iran NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 197. Egypt NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. NADPH Oxidase 4 Distributors List Table 201. NADPH Oxidase 4 Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. NADPH Oxidase 4 Image Figure 2. Global NADPH Oxidase 4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NADPH Oxidase 4 Market Size Share 2021 VS 2025 VS 2032 Figure 4. MTfp-siRNA Image Figure 5. GKT-831 Image Figure 6. GKT-136901 Image Figure 7. Others Image Figure 8. Global NADPH Oxidase 4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global NADPH Oxidase 4 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Liver Fibrosis Image Figure 11. Ischemic Stroke Image Figure 12. Kidney Fibrosis Image Figure 13. Kidney Disease Image Figure 14. Others Image Figure 15. Global NADPH Oxidase 4 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global NADPH Oxidase 4 Revenue (2021-2032) & (US$ Million) Figure 17. Global NADPH Oxidase 4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global NADPH Oxidase 4 Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global NADPH Oxidase 4 Revenue Market Share by Region (2021-2032) Figure 20. Global NADPH Oxidase 4 Sales (2021-2032) & (k units) Figure 21. Global NADPH Oxidase 4 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global NADPH Oxidase 4 Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico NADPH Oxidase 4 Sales YoY (2021-2032) & (k units) Figure 24. Europe NADPH Oxidase 4 Sales YoY (2021-2032) & (k units) Figure 25. China NADPH Oxidase 4 Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) NADPH Oxidase 4 Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa NADPH Oxidase 4 Sales YoY (2021-2032) & (k units) Figure 28. Global NADPH Oxidase 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global NADPH Oxidase 4 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global NADPH Oxidase 4 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global NADPH Oxidase 4 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global NADPH Oxidase 4 Revenue Market Share by Type (2021-2032) Figure 34. Global NADPH Oxidase 4 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global NADPH Oxidase 4 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global NADPH Oxidase 4 Sales Market Share by Type (2021-2032) Figure 37. Global NADPH Oxidase 4 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global NADPH Oxidase 4 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global NADPH Oxidase 4 Revenue Market Share by Application (2021-2032) Figure 40. Global NADPH Oxidase 4 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global NADPH Oxidase 4 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global NADPH Oxidase 4 Sales Market Share by Application (2021-2032) Figure 43. North America NADPH Oxidase 4 Revenue Share by Type (2021-2032) Figure 44. North America NADPH Oxidase 4 Sales Share by Type (2021-2032) Figure 45. North America NADPH Oxidase 4 Revenue Share by Application (2021-2032) Figure 46. North America NADPH Oxidase 4 Sales Share by Application (2021-2032) Figure 47. North America NADPH Oxidase 4 Revenue Share by Country (2021-2032) Figure 48. North America NADPH Oxidase 4 Sales Share by Country (2021-2032) Figure 49. Europe NADPH Oxidase 4 Revenue Share by Type (2021-2032) Figure 50. Europe NADPH Oxidase 4 Sales Share by Type (2021-2032) Figure 51. Europe NADPH Oxidase 4 Revenue Share by Application (2021-2032) Figure 52. Europe NADPH Oxidase 4 Sales Share by Application (2021-2032) Figure 53. Europe NADPH Oxidase 4 Revenue Share by Country (2021-2032) Figure 54. Europe NADPH Oxidase 4 Sales Share by Country (2021-2032) Figure 55. China NADPH Oxidase 4 Revenue Share by Type (2021-2032) Figure 56. China NADPH Oxidase 4 Sales Share by Type (2021-2032) Figure 57. China NADPH Oxidase 4 Revenue Share by Application (2021-2032) Figure 58. China NADPH Oxidase 4 Sales Share by Application (2021-2032) Figure 59. Asia NADPH Oxidase 4 Revenue Share by Type (2021-2032) Figure 60. Asia NADPH Oxidase 4 Sales Share by Type (2021-2032) Figure 61. Asia NADPH Oxidase 4 Revenue Share by Application (2021-2032) Figure 62. Asia NADPH Oxidase 4 Sales Share by Application (2021-2032) Figure 63. Asia NADPH Oxidase 4 Revenue Share by Country (2021-2032) Figure 64. Asia NADPH Oxidase 4 Sales Share by Country (2021-2032) Figure 65. SAMEA NADPH Oxidase 4 Revenue Share by Type (2021-2032) Figure 66. SAMEA NADPH Oxidase 4 Sales Share by Type (2021-2032) Figure 67. SAMEA NADPH Oxidase 4 Revenue Share by Application (2021-2032) Figure 68. SAMEA NADPH Oxidase 4 Sales Share by Application (2021-2032) Figure 69. SAMEA NADPH Oxidase 4 Revenue Share by Country (2021-2032) Figure 70. SAMEA NADPH Oxidase 4 Sales Share by Country (2021-2032) Figure 71. NADPH Oxidase 4 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. NADPH Oxidase 4 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • MTfp-siRNA
  • GKT-831
  • GKT-136901
  • Others
Applications
  • Liver Fibrosis
  • Ischemic Stroke
  • Kidney Fibrosis
  • Kidney Disease
  • Others
Companies covered
  • Bioasis Technologies Inc
  • GenKyoTex SA
  • Glucox Biotech AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 NADPH Oxidase 4 Market by Type
  3. 1.2.1 Global NADPH Oxidase 4 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MTfp-siRNA
  5. 1.2.3 GKT-831
  6. 1.2.4 GKT-136901
  7. 1.2.5 Others
  8. 1.3 NADPH Oxidase 4 Market by Application
  9. 1.3.1 Global NADPH Oxidase 4 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Liver Fibrosis
  11. 1.3.3 Ischemic Stroke
  12. 1.3.4 Kidney Fibrosis
  13. 1.3.5 Kidney Disease
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 NADPH Oxidase 4 Market Dynamics
  1. 2.1 NADPH Oxidase 4 Industry Trends
  2. 2.2 NADPH Oxidase 4 Industry Drivers
  3. 2.3 NADPH Oxidase 4 Industry Opportunities and Challenges
  4. 2.4 NADPH Oxidase 4 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global NADPH Oxidase 4 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global NADPH Oxidase 4 Revenue by Region
  3. 3.2.1 Global NADPH Oxidase 4 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global NADPH Oxidase 4 Revenue by Region (2021-2026)
  5. 3.2.3 Global NADPH Oxidase 4 Revenue by Region (2027-2032)
  6. 3.2.4 Global NADPH Oxidase 4 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global NADPH Oxidase 4 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global NADPH Oxidase 4 Sales by Region
  9. 3.4.1 Global NADPH Oxidase 4 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global NADPH Oxidase 4 Sales by Region (2021-2026)
  11. 3.4.3 Global NADPH Oxidase 4 Sales by Region (2027-2032)
  12. 3.4.4 Global NADPH Oxidase 4 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global NADPH Oxidase 4 Revenue by Manufacturers
  2. 4.1.1 Global NADPH Oxidase 4 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global NADPH Oxidase 4 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global NADPH Oxidase 4 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global NADPH Oxidase 4 Sales by Manufacturers
  6. 4.2.1 Global NADPH Oxidase 4 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global NADPH Oxidase 4 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global NADPH Oxidase 4 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global NADPH Oxidase 4 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global NADPH Oxidase 4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global NADPH Oxidase 4 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global NADPH Oxidase 4 Manufacturers, Product Type & Application
  13. 4.7 Global NADPH Oxidase 4 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global NADPH Oxidase 4 Market CR5 and HHI
  16. 4.8.2 2025 NADPH Oxidase 4 Tier 1, Tier 2, and Tier 3
5 NADPH Oxidase 4 Market by Type
  1. 5.1 Global NADPH Oxidase 4 Revenue by Type
  2. 5.1.1 Global NADPH Oxidase 4 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global NADPH Oxidase 4 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global NADPH Oxidase 4 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global NADPH Oxidase 4 Sales by Type
  6. 5.2.1 Global NADPH Oxidase 4 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NADPH Oxidase 4 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global NADPH Oxidase 4 Sales Market Share by Type (2021-2032)
  9. 5.3 Global NADPH Oxidase 4 Price by Type
6 NADPH Oxidase 4 Market by Application
  1. 6.1 Global NADPH Oxidase 4 Revenue by Application
  2. 6.1.1 Global NADPH Oxidase 4 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global NADPH Oxidase 4 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global NADPH Oxidase 4 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global NADPH Oxidase 4 Sales by Application
  6. 6.2.1 Global NADPH Oxidase 4 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global NADPH Oxidase 4 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global NADPH Oxidase 4 Sales Market Share by Application (2021-2032)
  9. 6.3 Global NADPH Oxidase 4 Price by Application
7 Company Profiles
  1. 7.1 Bioasis Technologies Inc
  2. 7.1.1 Bioasis Technologies Inc Company Information
  3. 7.1.2 Bioasis Technologies Inc Business Overview
  4. 7.1.3 Bioasis Technologies Inc NADPH Oxidase 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bioasis Technologies Inc NADPH Oxidase 4 Product Portfolio
  6. 7.1.5 Bioasis Technologies Inc Recent Developments
  7. 7.2 GenKyoTex SA
  8. 7.2.1 GenKyoTex SA Company Information
  9. 7.2.2 GenKyoTex SA Business Overview
  10. 7.2.3 GenKyoTex SA NADPH Oxidase 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GenKyoTex SA NADPH Oxidase 4 Product Portfolio
  12. 7.2.5 GenKyoTex SA Recent Developments
  13. 7.3 Glucox Biotech AB
  14. 7.3.1 Glucox Biotech AB Company Information
  15. 7.3.2 Glucox Biotech AB Business Overview
  16. 7.3.3 Glucox Biotech AB NADPH Oxidase 4 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Glucox Biotech AB NADPH Oxidase 4 Product Portfolio
  18. 7.3.5 Glucox Biotech AB Recent Developments
8 North America
  1. 8.1 North America NADPH Oxidase 4 Market Size by Type
  2. 8.1.1 North America NADPH Oxidase 4 Revenue by Type (2021-2032)
  3. 8.1.2 North America NADPH Oxidase 4 Sales by Type (2021-2032)
  4. 8.1.3 North America NADPH Oxidase 4 Price by Type (2021-2032)
  5. 8.2 North America NADPH Oxidase 4 Market Size by Application
  6. 8.2.1 North America NADPH Oxidase 4 Revenue by Application (2021-2032)
  7. 8.2.2 North America NADPH Oxidase 4 Sales by Application (2021-2032)
  8. 8.2.3 North America NADPH Oxidase 4 Price by Application (2021-2032)
  9. 8.3 North America NADPH Oxidase 4 Market Size by Country
  10. 8.3.1 North America NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America NADPH Oxidase 4 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe NADPH Oxidase 4 Market Size by Type
  2. 9.1.1 Europe NADPH Oxidase 4 Revenue by Type (2021-2032)
  3. 9.1.2 Europe NADPH Oxidase 4 Sales by Type (2021-2032)
  4. 9.1.3 Europe NADPH Oxidase 4 Price by Type (2021-2032)
  5. 9.2 Europe NADPH Oxidase 4 Market Size by Application
  6. 9.2.1 Europe NADPH Oxidase 4 Revenue by Application (2021-2032)
  7. 9.2.2 Europe NADPH Oxidase 4 Sales by Application (2021-2032)
  8. 9.2.3 Europe NADPH Oxidase 4 Price by Application (2021-2032)
  9. 9.3 Europe NADPH Oxidase 4 Market Size by Country
  10. 9.3.1 Europe NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe NADPH Oxidase 4 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China NADPH Oxidase 4 Market Size by Type
  2. 10.1.1 China NADPH Oxidase 4 Revenue by Type (2021-2032)
  3. 10.1.2 China NADPH Oxidase 4 Sales by Type (2021-2032)
  4. 10.1.3 China NADPH Oxidase 4 Price by Type (2021-2032)
  5. 10.2 China NADPH Oxidase 4 Market Size by Application
  6. 10.2.1 China NADPH Oxidase 4 Revenue by Application (2021-2032)
  7. 10.2.2 China NADPH Oxidase 4 Sales by Application (2021-2032)
  8. 10.2.3 China NADPH Oxidase 4 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia NADPH Oxidase 4 Market Size by Type
  2. 11.1.1 Asia NADPH Oxidase 4 Revenue by Type (2021-2032)
  3. 11.1.2 Asia NADPH Oxidase 4 Sales by Type (2021-2032)
  4. 11.1.3 Asia NADPH Oxidase 4 Price by Type (2021-2032)
  5. 11.2 Asia NADPH Oxidase 4 Market Size by Application
  6. 11.2.1 Asia NADPH Oxidase 4 Revenue by Application (2021-2032)
  7. 11.2.2 Asia NADPH Oxidase 4 Sales by Application (2021-2032)
  8. 11.2.3 Asia NADPH Oxidase 4 Price by Application (2021-2032)
  9. 11.3 Asia NADPH Oxidase 4 Market Size by Country
  10. 11.3.1 Asia NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia NADPH Oxidase 4 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA NADPH Oxidase 4 Market Size by Type
  2. 12.1.1 SAMEA NADPH Oxidase 4 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA NADPH Oxidase 4 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA NADPH Oxidase 4 Price by Type (2021-2032)
  5. 12.2 SAMEA NADPH Oxidase 4 Market Size by Application
  6. 12.2.1 SAMEA NADPH Oxidase 4 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA NADPH Oxidase 4 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA NADPH Oxidase 4 Price by Application (2021-2032)
  9. 12.3 SAMEA NADPH Oxidase 4 Market Size by Country
  10. 12.3.1 SAMEA NADPH Oxidase 4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA NADPH Oxidase 4 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA NADPH Oxidase 4 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 NADPH Oxidase 4 Value Chain Analysis
  2. 13.1.1 NADPH Oxidase 4 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 NADPH Oxidase 4 Production Mode & Process
  6. 13.2 NADPH Oxidase 4 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 NADPH Oxidase 4 Distributors
  9. 13.2.3 NADPH Oxidase 4 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst